Phase I study of gemcitabine given weekly as a short infusion for non-small cell lung cancer: results and possible immune system-related mechanisms.
暂无分享,去创建一个
T. Whiteside | M. Levitt | S. Yousem | R. Landreneau | R. Keenan | W. Gooding | P. Ferson | J. Sabatine | B. Kassem | L. Miketic | C. Lindberg | M. R. Trenn | R. S. Ponas | P. Tarasoff | D. Friberg | William E. Gooding | Theresa L. Whiteside | Rodney J. Landreneau | Mark L. Levitt | Robert J. Keenan